Laboratory ofCellTechnology [Purpose] Pluripotent stemcellsareproposed to be used in regenerative therapy andhavebeensuggested to exist in thehematopoietic system, intestinal tract, skelelal muscle, theskinand central neavous symn and their p-esence in thoselocations hasbeenconfinned. Plmipotent stem cells alsomayexist inthehwnananmiotic membrane. We established a pluripotent stemcellline from hwnan placenta.
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[Materials andMeU1ods] Amnion membrane ofhwnan full-tenn placenta were minced witha sharp pair of scissors intheculture mediwn containing 600PU/ml of Dispase for30min. and centrifuged at900rpmfor 10 min. The sediments were resuspended inthe growth medium, placed in 6-cm plastic dishes, andincubated at 37"Cin a humidified atmosphere containing 5% C~in air. The growth mediwn used was aMEM supplemented with lOO!o FBS, 10nglml ofLIF and 10ngimI of EGF. The small and round cells proliferated in multilayer were aspirated withmiCJ'Oo<:8J)illary, transferred to a new culture dish.
[Results and Conclusion] The amniotic stemcell sIrain (HAM-I) wasestablished andtheHMA-Icells grew rapidly and theserial passages were successively carried outSO times. The HAM-I cellswerecharacterized asthe following biological properties; They(i)werederived from thehuman amnion membrane, (ii) haveanability of self~uplication while maintaining an undifferentiated stale andnormal kmyotype, (iii) candifferentiate intoa 3 germ layer embryo with totipotency, and(iv) havehigh specific enzyme activity (alkaline phosphatase).
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In vitro dift'erentiation ofmouse embryonicstemceO into cardiomyocytes. 
Purpose
Autosomal dominant polycystic kidney disease (ADPKD) is one of most common inherited renal diseases, exhibiting cystic dilatation of renal ducts. Although the mutated genes, polycystin-l and polycystin-2 were identified, how these mutations cause cystic dilatation was unknown. We identified a potential molecular target of polycystins, . Makorin 1. Here, we will propose a new therapeutic strategy for ADPKD using Makorin 1. Methods We made mutant mouse exhibiting polycystic kidney and bone deformity by insertional mutagenesis. A mutated gene, Makorin1 carries RING finger motif, and supposed to be belong to Wnt signal pathway. First, we will identify an . interacting protein with Makorin1. Second, we will elucidate how MakorinI transduces signals. Finally, we will address the molecular mechanism of polycystic kidney associated with a mutation of Makorinl. Results We examined subcellular localization of Makorin1, and identified that Makorin1 is located in cell membrane and nucleus, suggesting that Makorin1 transduces signals from outside into nucleus. We designed several strategy to hunt interacting proteins with Makorin1. First, we made several antibodies to generate affinity column. Second, we generated GST-tagged Makorin1 for column purification. By these methods, we ro~nd se~eral . targets of Makorin1. We are determining ammo acid sequencing using MS. Conclusion Biochemical and developmental study suggested that MakorinI is present in the Wnt signal transduction pathway. We determined subcellular localization of Makorin1. Makorin1 are located at cell membrane and nucleus. We also found several interacting proteins with Makorin1. insulinoma group showed no metastasis togetherwith 1M expression in the lesions, while theother leT groups showed a high incidence of metastasis (82010) anda low expression rate of1M (6%). Toexamine thefimctionaJ role oflM, especially regarding theclinical chamcteristics ofIeTs, wetestedtheeffect ofexogenous1M overexpression on celladhesiveness andproliferation using MIN6 insulinoma cell line. Incell-based experiments, 1M overexpression reduced ceO proliferation, andenhanced ea2+-independent cellaggregation possibly through direct interaction with neural cell adhesion molecule (N-CAM). Taken together, these results are suggesting that 1M mayactas anti-metastatic molecule of insulinomas. In addition, 1M isa clinically useful molecular marker notonly for ident:iJYing fkeU-<>rigin ICTs (i.e., insulinomas) butalsoforpredicting disease prognosis ofICTs.
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